Bibliotecas PUC-SP - Busca Integrada

Intersection Between Large Granular Lymphocyte Leukemia and Rheumatoid Arthritis

Por Katharine B. Moosic, Katharine B. Moosic, Katharine B. Moosic, Kusuma Ananth, Felipe Andrade, David J. Feith, David J. Feith, Erika Darrah, Thomas P. Loughran, Thomas P. Loughran
Publicado no Frontiers in Oncology (2022-05-01)

LGL leukemia patients exhibit substantial protective humoral responses following SARS‐CoV‐2 vaccination

Por Heejin Cheon, Omar Elghawy, Bryna C. Shemo, David J. Feith, Thomas P. Loughran Jr.
Publicado no eJHaem (2022-08-01)

Inference of Network Dynamics and Metabolic Interactions in the Gut Microbiome.

Por Steven N Steinway, Matthew B Biggs, Thomas P Loughran, Jason A Papin, Reka Albert
Publicado no PLoS Computational Biology (2015-05-01)

Emergence of a STAT3 mutated NK clone in LGL leukemia

Por Yiyi Yan, Thomas L. Olson, Susan B. Nyland, David J. Feith, Thomas P. Loughran Jr.
Publicado no Leukemia Research Reports (2015-01-01)

Dynamical and structural analysis of a T cell survival network identifies novel candidate therapeutic targets for large granular lymphocyte leukemia.

Por Assieh Saadatpour, Rui-Sheng Wang, Aijun Liao, Xin Liu, Thomas P Loughran, István Albert, Réka Albert
Publicado no PLoS Computational Biology (2011-11-01)

Genome-wide mapping of histone H3K9me2 in acute myeloid leukemia reveals large chromosomal domains associated with massive gene silencing and sites of genome instability.

Por Anna C Salzberg, Abigail Harris-Becker, Evgenya Y Popova, Nikki Keasey, Thomas P Loughran, David F Claxton, Sergei A Grigoryev
Publicado no PLoS ONE (2017-01-01)

Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.

Por Paige M Kulling, Kristine C Olson, Cait E Hamele, Mariella F Toro, Su-Fern Tan, David J Feith, Thomas P Loughran
Publicado no PLoS ONE (2018-01-01)

Retrovirus insertion site analysis of LGL leukemia patient genomes

Por Weiling Li, Lei Yang, Robert S. Harris, Lin Lin, Thomas L. Olson, Cait E. Hamele, David J. Feith, Thomas P. Loughran, Mary Poss
Publicado no BMC Medical Genomics (2019-06-01)

Somatic STAT3 mutations in Felty syndrome: an implication for a common pathogenesis with large granular lymphocyte leukemia

Por Paula Savola, Oscar Brück, Thomas Olson, Tiina Kelkka, Markku J. Kauppi, Panu E. Kovanen, Soili Kytölä, Tuulikki Sokka-Isler, Thomas P. Loughran, Marjatta Leirisalo-Repo, Satu Mustjoki
Publicado no Haematologica (2018-02-01)

Whole Genome Sequencing of Spontaneously Occurring Rat Natural Killer Large Granular Lymphocyte Leukemia Identifies JAK1 Somatic Activating Mutation

Por T. Tiffany Wang, Jun Yang, Shubha Dighe, Matthew W. Schmachtenberg, Nathan T. Leigh, Emily Farber, Suna Onengut-Gumuscu, David J. Feith, Aakrosh Ratan, Thomas P. Loughran, Thomas L. Olson
Publicado no Cancers (2020-01-01)

The novel Isatin analog KS99 targets stemness markers in acute myeloid leukemia

Por Charyguly Annageldiyev, Krishne Gowda, Trupti Patel, Priyanjali Bhattacharya, Su-Fern Tan, Soumya Iyer, Dhimant Desai, Sinisa Dovat, David J. Feith, Thomas P. Loughran, Shantu Amin, David Claxton, Arati Sharma
Publicado no Haematologica (2020-03-01)

Large granular lymphocyte leukemia serum and corresponding hematological parameters reveal unique cytokine and sphingolipid biomarkers and associations with STAT3 mutations

Por Kristine C. Olson, Katharine B. Moosic, Marieke K. Jones, Paige M. K. Larkin, Thomas L. Olson, Mariella F. Toro, Todd E. Fox, David J. Feith, Thomas P. Loughran Jr
Publicado no Cancer Medicine (2020-09-01)

The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia

Por Charyguly Annageldiyev, Charyguly Annageldiyev, Su-Fern Tan, Shreya Thakur, Pavan Kumar Dhanyamraju, Srinivasa R. Ramisetti, Preeti Bhadauria, Jacob Schick, Zheng Zeng, Varun Sharma, Wendy Dunton, Sinisa Dovat, Dhimant Desai, Dhimant Desai, Hong Zheng, Hong Zheng, David J. Feith, David J. Feith, Thomas P. Loughran, Thomas P. Loughran, Shantu Amin, Shantu Amin, Arun K. Sharma, Arun K. Sharma, David Claxton, David Claxton, Arati Sharma, Arati Sharma, Arati Sharma
Publicado no Frontiers in Oncology (2020-04-01)

A fluorogenic substrate for the detection of lipid amidases in intact cells

Por Mireia Casasampere, Johnson Ung, Alejandro Iñáñez, Carine Dufau, Kazuhito Tsuboi, Josefina Casas, Su-Fern Tan, David J. Feith, Nathalie Andrieu-Abadie, Bruno Segui, Thomas P. Loughran, Jr., José Luis Abad, Gemma Fabrias
Publicado no Journal of Lipid Research (2024-03-01)

A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma

Por Jeffrey J. Pu, Jeffrey J. Pu, Kristin N. Berger, Chunlei Zheng, Chunlei Zheng, Nhan Do, Nhan Do, David F. Claxton, W. Christopher Ehmann, Joseph J. Drabick, Haiquan Li, Thomas P. Loughran, Elliot M. Epner
Publicado no Frontiers in Oncology (2024-12-01)

DJ4 Targets the Rho-Associated Protein Kinase Pathway and Attenuates Disease Progression in Preclinical Murine Models of Acute Myeloid Leukemia

Por Upendarrao Golla, Melanie A. Ehudin, Charyguly Annageldiyev, Zheng Zeng, Diwakar Bastihalli Tukaramrao, Anna Tarren, Abhijit A. Date, Irina Elcheva, Arthur Berg, Shantu Amin, Thomas P. Loughran, Mark Kester, Dhimant Desai, Sinisa Dovat, David Claxton, Arati Sharma
Publicado no Cancers (2021-09-01)

Activating STAT3 mutations in CD8+ T-cells correlate to serological positivity in rheumatoid arthritis

Por Katharine B. Moosic, Katharine B. Moosic, Katharine B. Moosic, Thomas L. Olson, Thomas L. Olson, Mark Freijat, Samara Khalique, Cait E. Hamele, Cait E. Hamele, Bryna Shemo, Bryna Shemo, Jesse Boodoo, William Baker, Gitanjali Khurana, Matthew Schmachtenberg, Matthew Schmachtenberg, Tristin Duffy, Tristin Duffy, Aakrosh Ratan, Aakrosh Ratan, Aakrosh Ratan, Erika Darrah, Felipe Andrade, Marieke Jones, Kristine C. Olson, Kristine C. Olson, David J. Feith, David J. Feith, Donald L. Kimpel, Thomas P. Loughran, Thomas P. Loughran
Publicado no Frontiers in Immunology (2024-10-01)

The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia

Por Hanna L. M. Rajala, Thomas Olson, Michael J. Clemente, Sonja Lagström, Pekka Ellonen, Tuija Lundan, David E. Hamm, Syed Arshi Uz Zaman, Jesus M. Lopez Marti, Emma I. Andersson, Andres Jerez, Kimmo Porkka, Jaroslaw P. Maciejewski, Thomas P. Loughran, Satu Mustjoki
Publicado no Haematologica (2015-01-01)

Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation

Por Su-Fern Tan, Wendy Dunton, Xin Liu, Todd E. Fox, Samy A.F. Morad, Dhimant Desai, Kenichiro Doi, Mark R. Conaway, Shantu Amin, David F. Claxton, Hong-Gang Wang, Mark Kester, Myles C. Cabot, David J. Feith, Thomas P. Loughran, Jr.
Publicado no Journal of Lipid Research (2019-06-01)

SKI-178: A multitargeted inhibitor of sphingosine kinase and microtubule dynamics demonstrating therapeutic efficacy in acute myeloid leukemia models

Por Jeremy A Hengst, Taryn E Dick, Arati Sharma, Kenichiro Doi, Shailaja Hegde, Su-Fern Tan, Laura M Geffert, Todd E Fox, Arun K Sharma, Dhimant Desai, Shantu Amin, Mark Kester, Thomas P Loughran, Robert F Paulson, David F Claxton, Hong-Gang Wang, Jong K Yun
Publicado no Cancer Translational Medicine (2017-01-01)